Results 161 to 170 of about 24,713 (214)

Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. [PDF]

Rheumatology (Oxford)
Carnazzo V, Gulli F, Basile V, Di Santo R, Niccolini B, Redi S, Vinante I, Napodano C, Pocino K, Rapaccini GL, Lizzio MM, Marino M, Ciasca G, Basile U.   +13 more
europepmc   +1 more source

Acute Vascular Response to Hemodialysis as Measured by Serum Syndecan-1 and Endothelin-1 Levels as Well as Vascular Stiffness. [PDF]

J Clin Med, 2023
Sági B, Kun S, Jakabfi-Csepregi RK, Sulyok E, Csiky B.   +4 more
europepmc   +1 more source

Syndecan-1 as a predictor of vulnerable atherosclerotic plaques. [PDF]

Front Cell Dev Biol
Qiu Y, Ouyang Z, Zhong J, Jin L, Qin Y, Zeng Y.   +5 more
europepmc   +1 more source

Syndecan-1 as a severity biomarker for patients with trauma. [PDF]

Front Med (Lausanne), 2022
Suzuki K, Okada H, Sumi K, Tomita H, Kobayashi R, Ishihara T, Mizuno Y, Yamaji F, Kamidani R, Miura T, Yasuda R, Kitagawa Y, Fukuta T, Suzuki K, Miyake T, Kanda N, Doi T, Yoshida T, Yoshida S, Tetsuka N, Ogura S, Suzuki A.   +21 more
europepmc   +1 more source

Syndecan‑1 expression is an independent favourable prognostic marker in oesophageal adenocarcinoma and represents a potential therapeutic target. [PDF]

Oncol Lett, 2023
Akca D, Simon A, Buettner R, Bruns C, Schroeder W, Zander T, Gebauer F, Quaas A.   +7 more
europepmc   +1 more source

Tranexamic acid did not attenuate the acute rise in plasma syndecan-1 in a severely injured cohort: a laboratory analysis of the PATCH clinical trial. [PDF]

Intensive Care Med Exp
Milford EM, Marjanovic D, Ho H, Wallis S, Draxler DF, Mitra B, Gruen RL, Medcalf R, Bernard S, McArthur C, Meagele M, Burns B, Gantner D, Reade MC.   +13 more
europepmc   +1 more source

Sneaky Staph Can Shed Syndecan-1 [PDF]

Journal of Biological Chemistry, 2011
openaire   +1 more source

Syndecan-1-mediated loading of VEGF-A into small extracellular vesicles facilitates peritubular capillary repair during AKI-to-CKD transition. [PDF]

iScience
Zhong X, Tang TT, Zhang Y, Xue DD, Shen AR, Li N, Wu M, Liu BC, Lv LL.   +8 more
europepmc   +1 more source

Decreased expression of Syndecan- 1 (CD138) in the endometrium of adenomyosis patients suggests a potential pathogenetic role. [PDF]

Acta Obstet Gynecol Scand
Shaalan W, Ibrahim MG, Plasger A, Hassan N, Kiesel L, Schüring AN, Götte M.   +6 more
europepmc   +1 more source

Syndecan-1 Levels in Females with Active Rheumatoid Arthritis. [PDF]

J Clin Med
Rodriguez-Jimenez NA, Gonzalez-Ponce F, Gamez-Nava JI, Ramirez-Villafaña M, Saldaña-Cruz AM, Ponce-Guarneros JM, Olivas-Flores EM, Macías-Islas MA, Valdivia-Tangarife ER, Jacobo-Cuevas H, Ramos-Estrada LG, Totsuka-Sutto S, Cardona-Muñoz EG, Gonzalez-Lopez L, On Behalf Of The Group For The Assessment Of Prognosis Biomarkers In Autoimmune Disorders.   +14 more
europepmc   +1 more source